Huang Yu-Shu, Guilleminault Christian, Li Hsueh-Yu, Yang Chien-Ming, Wu Yu-Yu, Chen Ning-Hung
Department of Child Psychiatry, Chang Gung Memorial University Hospital, Tao-Yuan, Taipei, Taiwan.
Sleep Med. 2007 Jan;8(1):18-30. doi: 10.1016/j.sleep.2006.05.016. Epub 2006 Dec 6.
Children diagnosed with attention-deficit/hyperactivity disorder (ADHD), based on Diagnostic and Statistical Manual of Mental Disorders, Fourth edition (DSM-IV) criteria, may also have obstructive sleep apnea (OSA), but it is unclear whether treating OSA has similar results as methylphenidate (MPH), a commonly used treatment for ADHD.
This study enrolled 66 school-age children, referred for and diagnosed with ADHD, and 20 healthy controls. Polysomnography (PSG) performed after ADHD diagnosis showed the presence of mild OSA. After otolaryngological evaluation, parents and referring physicians of the children could select treatment of ADHD with MPH, treatment of OSA with adenotonsillectomy or no treatment. Systematic follow-up was performed six months after initiation of treatment, or diagnosis if no treatment. All children had pre- and post-clinical interviews; pediatric, neurologic, psychiatric and neurocognitive evaluation; PSG; ADHD rating scale, child behavior checklist (CBCL) filled out by parents and teacher; test of variables of attention (TOVA); and the quality of life in children with obstructive sleep disorder questionnaire (OSA-18).
ADHD children had an apnea-hypopnea index (AHI)>1<5 event/hour; 27 were treated with MPH, 25 had adenotonsillectomy, and 14 had no treatment. The surgical and MPH groups improved more than the non-treatment group. When comparing MPH to post-surgery, the PSG and questionnaire sleep variables, some daytime symptoms (including attention span) and TOVA subscales (impulse control, response time and total ADHD score) improved more in the surgical group than the MPH group. The surgical group had an ADHD total score of 21.16+/-7.13 on the ADHD rating scale (ADHD-RS) post-surgery compared to 31.52+/-7.01 pre-surgery (p=0.0001), and the inattention and hyperactivity subscales were also significantly lower (p=0.0001). Finally, the results were significantly different between surgically and MPH-treated groups (ADHD-RS p=0.007). The surgical group also had a TOVA ADHD score lower than -1.8 and close to those obtained in normal controls.
A low AHI score of >1 considered abnormal is detrimental to children with ADHD. Recognition and surgical treatment of underlying mild sleep-disordered breathing (SDB) in children with ADHD may prevent unnecessary long-term MPH usage and the potential side effects associated with drug intake.
根据《精神疾病诊断与统计手册》第四版(DSM-IV)标准诊断为注意力缺陷多动障碍(ADHD)的儿童,也可能患有阻塞性睡眠呼吸暂停(OSA),但尚不清楚治疗OSA是否与治疗ADHD常用药物哌甲酯(MPH)有相似效果。
本研究纳入66名被转诊并诊断为ADHD的学龄儿童和20名健康对照者。ADHD诊断后进行的多导睡眠图(PSG)检查显示存在轻度OSA。经耳鼻喉科评估后,这些儿童的家长和转诊医生可选择用MPH治疗ADHD、行腺样体扁桃体切除术治疗OSA或不进行治疗。治疗开始后6个月进行系统随访,若未治疗则在诊断后6个月进行随访。所有儿童均进行治疗前后的临床访谈;儿科、神经科、精神科和神经认知评估;PSG检查;ADHD评定量表、家长和教师填写的儿童行为清单(CBCL);注意力变量测试(TOVA);以及阻塞性睡眠障碍儿童生活质量问卷(OSA-18)。
ADHD儿童的呼吸暂停低通气指数(AHI)>1<5次/小时;27名接受MPH治疗,25名接受腺样体扁桃体切除术,14名未接受治疗。手术组和MPH治疗组的改善情况均优于未治疗组。将MPH治疗组与手术后组进行比较时,PSG和问卷睡眠变量、一些日间症状(包括注意力持续时间)以及TOVA分量表(冲动控制、反应时间和ADHD总分)在手术组的改善程度大于MPH治疗组。手术组术后ADHD评定量表(ADHD-RS)的ADHD总分是21.16±7.13,术前为31.52±7.01(p=0.0001),注意力不集中和多动分量表得分也显著降低(p=0.0001)。最后,手术治疗组和MPH治疗组的结果存在显著差异(ADHD-RS p=0.007)。手术组的TOVA ADHD得分也低于-1.8,接近正常对照组的得分。
AHI得分>1被认为异常这一较低水平对ADHD儿童有害。识别并手术治疗ADHD儿童潜在的轻度睡眠呼吸障碍(SDB),可能避免不必要的长期MPH使用以及与药物摄入相关的潜在副作用。